Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Adult Patients With Bronchial Asthma
NCT00242307Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2004
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Roflumilast with Placebo (2 arms). Primary endpoint: Change in lung function parameters at 24 weeks. Started May 2004; status: completed.
02
Drugs
roflumilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00242307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242307.